A Prospective Phase II Study of Combined Androgen Blockade in Patients With Androgen Receptor-Positive Metastatic or Locally Advanced Unresectable Salivary Gland Carcinoma

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx771